Bridgebio is funding the MDA with $100,000 to advance projects aimed at improving multidisciplinary care for people with LGMD ...

His daughter's graduation was a special day for columnist Robin Stemple and his family. But accessibility issues rained on ...

Duchenne Parent Project Spain is investing €247,000 in a project to create a new laboratory model to study heart health in ...

Columnist Betty Vertin shares a conversation with her daughter Lexi about finding out she was not a DMD gene carrier.

Epicrispr Biotechnologies is partnering with Forge Biologics to support the development of EPI-321, an one-time epigentic ...

My dear friend Colin Rensch had a saying: “If you think you can, then of course you can.” I met Colin because I live with limb-girdle muscular dystrophy, and he lived with Duchenne muscular dystrophy.

As columnist Shalom Lim continues to process the loss of a dear friend, he explains why DMD advocacy work is his calling in ...

Regulators in the European Union granted orphan drug designation to SGT-003, an experimental gene therapy for Duchenne ...

This article was provided by our partner, the Muscular Dystrophy Association. It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and ...

Columnist Betty Vertin saw her oldest sons lose their ability to move, but that doesn't make seeing it happen to her youngest son any easier.

Alena Jones, 20, lives with facioscapulohumeral muscular dystrophy; she was diagnosed at 13. Through sharing her story, Alena hopes to connect with others facing similar challenges and show that life ...

The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to (Z)-endoxifen for Duchenne muscular dystrophy (DMD), a step that could allow its developer, Atossa ...